John Paulson: M&A Activity Likely To Continue

John Paulson, founder of hedge fund firm Paulson & Co., said corporate merger and acquisition activity “will continue for the foreseeable future.”

We will be covering the conference – sign up for our newsletter to ensure you get all the updates.

Charlie Munger: Invert And Use “Disconfirming Evidence”

Charlie MungerCharlie Munger is considered to be one of the best investors and thinkers alive today. His thoughts and statements on investment research, investment psychology, and general rational behavior are often incredibly insightful. Anyone can learn something from this billionaire investor and philosopher. Q2 2020 hedge fund letters, conferences and more If you’re looking for value Read More


John Paulson: M&A activity to continue for foreseeable future

John Paulson on Allergan as Valeant takeover target

John Paulson, founder of hedge fund firm Paulson & Co., said Allergan, Inc. (NYSE:AGN) shares could be worth $222 a share as a result of a potential takeover by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX).